These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33597362)

  • 61. Hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumor thrombosis.
    Lai YC; Shih CY; Jeng CM; Yang SS; Hu JT; Sung YC; Liu HT; Hou SM; Wu CH; Chen TK
    World J Gastroenterol; 2003 Dec; 9(12):2666-70. PubMed ID: 14669309
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Hepatocellular carcinoma: resection with adjuvant hepatic artery infusion therapy vs resection alone. A systematic review and meta-analysis.
    Moran A; Ramos LF; Picado O; Pendola F; Sleeman D; Dudeja V; Merchant N; Yakoub D
    J Surg Oncol; 2019 Mar; 119(4):455-463. PubMed ID: 30575028
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hepatic intra-arterial cetuximab in combination with 5-fluorouracil and cisplatin as salvage treatment for sorafenib-refractory hepatocellular carcinoma.
    Poggi G; Montagna B; Melchiorre F; Quaretti P; Delmonte A; Riccardi A; Tagliaferri B; Sottotetti F; Di Cesare P; Stella MG; Villani L; Zorzetto M; Greco G; Cornalba G; Bernardo G
    Anticancer Res; 2011 Nov; 31(11):3927-33. PubMed ID: 22110221
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Adjuvant hepatic arterial infusion chemotherapy after radical hepatectomy for hepatocellular carcinoma--results of long-term follow-up.
    Asahara T; Itamoto T; Katayama K; Ono E; Dohi K; Nakanishi T; Kitamoto M; Azuma K; Ito K
    Hepatogastroenterology; 1999; 46(26):1042-8. PubMed ID: 10370664
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Advanced hepatocellular carcinoma with hepatic vein tumor thrombosis and renal dysfunction after hepatic arterial infusion chemotherapy effectively treated by liver resection with active veno-venous bypass: report of a case.
    Itoh A; Sadamori H; Yabushita K; Monden K; Tatsukawa M; Hioki M; Hyodo T; Omonishi K; Ueki T; Ohno S; Sakaguchi K; Takakura N
    BMC Cancer; 2016 Sep; 16(1):705. PubMed ID: 27586890
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [New approach for unresectable primary liver cancer--intra-arterial combination chemotherapy during and after operation with local injection of ethanol].
    Shiga T; Noguchi T; Nishimaki K; Kudo M
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2765-8. PubMed ID: 2551220
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Significance of hepatic resection and adjuvant hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumor thrombus in the first branch of portal vein and the main portal trunk: a project study for hepatic surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
    Hatano E; Uemoto S; Yamaue H; Yamamoto M;
    J Hepatobiliary Pancreat Sci; 2018 Sep; 25(9):395-402. PubMed ID: 30091239
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cost-effectiveness and prognostic model of hepatic arterial infusion chemotherapy for hepatocellular carcinoma with high tumor burden and/or Vp4 tumor thrombus compared with sorafenib: a post-hoc analysis of the FOHAIC-1 trial.
    Chen QF; Lyu N; Wang X; Jiang XY; Hu Y; Chen S; Zhong SX; Huang ZL; Chen M; Zhao M
    Int J Surg; 2023 Dec; 109(12):3929-3939. PubMed ID: 37678272
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antitumor effect of sorafenib and mammalian target of rapamycin inhibitor in liver transplantation recipients with hepatocellular carcinoma recurrence.
    Jung DH; Tak E; Hwang S; Song GW; Ahn CS; Kim KH; Moon DB; Ha TY; Park GC; Ryoo BY; Lee KJ; Kim N; Kwon JH; Jwa EK; Lee SG
    Liver Transpl; 2018 Jul; 24(7):932-945. PubMed ID: 29710388
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [An effective case of arterial infusion therapy of low-dose CDDP and continuous 5-FU for isolated hepatic recurrence of gastric carcinoma].
    Akamo Y; Takeyama H; Mohri N; Teranishi F; Ohara E; Kawashima N; Hayakawa T; Fukui T; Tanaka M; Mizuno I; Manabe T
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1945-7. PubMed ID: 10560432
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Adjuvant hepatic arterial infusion chemotherapy in patients with resected hepatocellular carcinoma with microvascular invasion.
    Tsilimigras DI; Pawlik TM
    Chin Clin Oncol; 2024 Feb; 13(1):16. PubMed ID: 37953245
    [No Abstract]   [Full Text] [Related]  

  • 72. Determinants of pain in advanced HCC patients recieving hepatic artery infusion chemotherapy.
    Wu Z; Guo W; Chen S; Zhuang W
    Invest New Drugs; 2021 Apr; 39(2):394-399. PubMed ID: 33006020
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Study of hepatic arterial infusion chemotherapy for prophylaxis of liver metastases of colorectal cancer after hepatic resection].
    Hanada H; Umekita N; Maeshiro T; Miyamoto S; Yamada F; Awane Y
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1497-9. PubMed ID: 7574742
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Successful hepatic arterial infusion therapy of CDDP/5-FU/IFN-beta3 for recurrent hepatocellular carcinoma].
    Baba H; Matsumoto G; Tsuruta K; Okamoto A; Hara Y; Endo M; Irie T; Arii S
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1705-7. PubMed ID: 15553689
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [A case of postoperative recurrence of hepatocellular carcinoma successfully treated with arterial infusion chemotherapy using cisplatin and 5-fluorouracil].
    Jibiki M; Taniguchi Y; Matsuo T; Ikari H; Ishibashi T; Sugamura Y; Kunizaki T; Hirao K
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2151-3. PubMed ID: 9388528
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [A case of recurrent hepatocellular carcinoma successfully treated with a combination therapy of interferon-alpha and intravenous continuous infusion of 5-fluorouracil].
    Katsuramaki T; Furuhata T; Kimura Y; Yamaguchi K; Ohmura T; Hata F; Mukaiya M; Hirata K
    Gan To Kagaku Ryoho; 2002 Oct; 29(10):1801-4. PubMed ID: 12402433
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A new therapeutic assessment score for advanced hepatocellular carcinoma patients receiving hepatic arterial infusion chemotherapy.
    Saeki I; Yamasaki T; Tanabe N; Iwamoto T; Matsumoto T; Urata Y; Hidaka I; Ishikawa T; Takami T; Yamamoto N; Uchida K; Terai S; Sakaida I
    PLoS One; 2015; 10(5):e0126649. PubMed ID: 25992784
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy of sequential sorafenib plus hepatic arterial infusion chemotherapy in patients with Barcelona Clinic Liver Cancer stage B and C hepatocellular carcinoma: a retrospective single-institution study.
    Ikuta S; Aihara T; Yamanaka N
    Contemp Oncol (Pozn); 2018; 22(3):165-171. PubMed ID: 30455588
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hepatic arterial infusion chemotherapy in combination with pegylated interferon-α-2b for advanced hepatocellular carcinoma.
    Okita K; Yamasaki T; Hamabe S; Saeki I; Harima Y; Terai S; Sakaida I
    Hepatogastroenterology; 2012; 59(114):533-7. PubMed ID: 22353519
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparison of hepatic arterial infusion chemotherapy and sorafenib in elderly patients with advanced hepatocellular carcinoma: A case series.
    Nemoto T; Matsuda H; Nosaka T; Saito Y; Ozaki Y; Hayama R; Naito T; Takahashi K; Ofuji K; Ohtani M; Hiramatsu K; Suto H; Nakamoto Y
    Mol Clin Oncol; 2014 Nov; 2(6):1028-1034. PubMed ID: 25279193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.